Inside Innovation

CalmWave, a Seattle-based health-tech startup, recently announced it raised $4.4 million in new funding. The company’s Calm ICU software eliminates unnecessary alarms in hospital intensive

TerraPower, a Bellevue-based nuclear power company, raised $650 million to support the development of its Natrium reactor and energy storage system, one of the fastest

AGC Biologics will launch cell therapy process development and clinical manufacturing services in Asia starting July 1, 2025, at AGC Inc.’s Yokohama Technical Center. This

For the first time ever, scientists have developed a precise genetic toolkit that can target the exact nerve cells destroyed by ALS and potentially deliver

Xaira Therapeutics, a spinout of the University of Washington’s Institute for Protein Design (IPD), recently released the largest publicly available Perturb-seq dataset to research how

Washington Research Foundation (WRF) has awarded a $275,000 grant to Dr. David Koelle, a professor of Medicine and Laboratory Medicine & Pathology at the University

Spokane Community College partnered with Jubilant HollisterStier to launch a biomanufacturing training program this semester. The Introduction to Biomanufacturing program covers basic biomanufacturing operations and

At a recent Life Science Washington event in Spokane, local health and research leaders warned that proposed NIH funding cuts could jeopardize medical research, jobs,

Bristol Myers Squibb (BMS), through its subsidiary RayzeBio, has entered a $1.35 billion licensing agreement with Swiss biotech firm Philochem centered around OncoACP3, a radiopharmaceutical

Seattle-based Perspective Therapeutics came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, signaling growing momentum in targeted radiopharmaceuticals. One of the company’s

Two Spokane-based innovation clusters have each secured $140,000 through the Washington State Department of Commerce’s Innovation Cluster Accelerator Program. The Evergreen Bioscience Innovation Cluster will